Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Actin-related protein 6 (ARP6; encoded by the ACTR6 gene) is a nuclear actin superfamily member that participates in chromatin remodeling, nucleolus organization, and regulation of ribosomal DNA transcription. ARP6 is a component of the SRCAP chromatin remodeling complex, which is essential for depositing the histone variant H2A.Z in chromatin and thereby influences nucleolar morphology and gene expression. ARP6 shows dynamic, pleiotropic roles under metabolic stress and is required for ribosomal gene regulation and cell survival. While it is a critical nuclear protein for chromosome architecture and cellular homeostasis, there is no evidence to date supporting its use as a therapeutic target, biomarker, or drug-interaction partner.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Actin-related protein 6 (ARP6).